Sagittarius Life Science Corp (TPEX:3205)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
58.00
+0.20 (0.35%)
Apr 28, 2026, 1:30 PM CST
150.54%
Market Cap 3.92B
Revenue (ttm) 346.08M
Net Income (ttm) -49.56M
Shares Out 67.55M
EPS (ttm) -0.92
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 131,660
Average Volume 987,743
Open 57.80
Previous Close 57.80
Day's Range 57.50 - 58.80
52-Week Range 22.75 - 67.00
Beta 0.49
RSI 50.67
Earnings Date Mar 27, 2026

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 112
Stock Exchange Taipei Exchange
Ticker Symbol 3205
Full Company Profile

Financial Performance

In 2025, Sagittarius Life Science's revenue was 346.08 million, a decrease of -26.01% compared to the previous year's 467.75 million. Losses were -49.56 million, 2.13% more than in 2024.

Financial Statements

News

There is no news available yet.